nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—MMP9—abdominal aortic aneurysm	0.747	1	CbGaD
Minocycline—MMP9—tunica intima—abdominal aortic aneurysm	0.0117	0.116	CbGeAlD
Minocycline—IL1B—leg—abdominal aortic aneurysm	0.00875	0.0868	CbGeAlD
Minocycline—IL1B—hindlimb—abdominal aortic aneurysm	0.00782	0.0775	CbGeAlD
Minocycline—MMP9—hindlimb—abdominal aortic aneurysm	0.00651	0.0646	CbGeAlD
Minocycline—CASP3—artery—abdominal aortic aneurysm	0.006	0.0595	CbGeAlD
Minocycline—CYCS—blood plasma—abdominal aortic aneurysm	0.00525	0.0521	CbGeAlD
Minocycline—IL1B—artery—abdominal aortic aneurysm	0.00479	0.0475	CbGeAlD
Minocycline—CASP3—blood plasma—abdominal aortic aneurysm	0.0045	0.0446	CbGeAlD
Minocycline—MMP9—artery—abdominal aortic aneurysm	0.00399	0.0396	CbGeAlD
Minocycline—IL1B—blood plasma—abdominal aortic aneurysm	0.00359	0.0356	CbGeAlD
Minocycline—MMP9—blood plasma—abdominal aortic aneurysm	0.003	0.0297	CbGeAlD
Minocycline—CASP1—connective tissue—abdominal aortic aneurysm	0.00291	0.0288	CbGeAlD
Minocycline—CYCS—connective tissue—abdominal aortic aneurysm	0.0028	0.0277	CbGeAlD
Minocycline—CASP1—kidney—abdominal aortic aneurysm	0.00247	0.0245	CbGeAlD
Minocycline—CASP3—connective tissue—abdominal aortic aneurysm	0.0024	0.0238	CbGeAlD
Minocycline—CYCS—kidney—abdominal aortic aneurysm	0.00238	0.0236	CbGeAlD
Minocycline—CASP3—kidney—abdominal aortic aneurysm	0.00204	0.0202	CbGeAlD
Minocycline—CASP1—spinal cord—abdominal aortic aneurysm	0.00193	0.0191	CbGeAlD
Minocycline—IL1B—connective tissue—abdominal aortic aneurysm	0.00191	0.019	CbGeAlD
Minocycline—CYCS—spinal cord—abdominal aortic aneurysm	0.00185	0.0184	CbGeAlD
Minocycline—IL1B—kidney—abdominal aortic aneurysm	0.00163	0.0162	CbGeAlD
Minocycline—MMP9—connective tissue—abdominal aortic aneurysm	0.00159	0.0158	CbGeAlD
Minocycline—CASP3—spinal cord—abdominal aortic aneurysm	0.00159	0.0158	CbGeAlD
Minocycline—MMP9—kidney—abdominal aortic aneurysm	0.00136	0.0135	CbGeAlD
Minocycline—SLC22A11—kidney—abdominal aortic aneurysm	0.00129	0.0128	CbGeAlD
Minocycline—IL1B—spinal cord—abdominal aortic aneurysm	0.00127	0.0126	CbGeAlD
Minocycline—ALOX5—connective tissue—abdominal aortic aneurysm	0.00126	0.0125	CbGeAlD
Minocycline—SLC22A7—kidney—abdominal aortic aneurysm	0.00126	0.0125	CbGeAlD
Minocycline—VEGFA—spinal cord—abdominal aortic aneurysm	0.00125	0.0124	CbGeAlD
Minocycline—MMP9—spinal cord—abdominal aortic aneurysm	0.00106	0.0105	CbGeAlD
Minocycline—SLC22A8—kidney—abdominal aortic aneurysm	0.000726	0.0072	CbGeAlD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00066	0.00433	CbGpPWpGaD
Minocycline—MMP9—Osteopontin-mediated events—MMP2—abdominal aortic aneurysm	0.000659	0.00432	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—AAAS—abdominal aortic aneurysm	0.000654	0.00428	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.000643	0.00421	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—MMP2—abdominal aortic aneurysm	0.000642	0.00421	CbGpPWpGaD
Minocycline—MMP9—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.000642	0.00421	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.000627	0.00411	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—NFKB1—abdominal aortic aneurysm	0.000617	0.00404	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.000606	0.00397	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.000604	0.00396	CbGpPWpGaD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—NFKB1—abdominal aortic aneurysm	0.000601	0.00394	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—abdominal aortic aneurysm	0.000601	0.00394	CbGpPWpGaD
Minocycline—IL1B—IL1-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.000593	0.00389	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—NOS2—abdominal aortic aneurysm	0.00059	0.00387	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—abdominal aortic aneurysm	0.000572	0.00375	CbGpPWpGaD
Minocycline—IL1B—IL-1 signaling pathway—CCL2—abdominal aortic aneurysm	0.000571	0.00374	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000569	0.00373	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.000567	0.00372	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000566	0.00371	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—APOE—abdominal aortic aneurysm	0.000562	0.00368	CbGpPWpGaD
Minocycline—MMP9—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00056	0.00367	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—MMP9—abdominal aortic aneurysm	0.00056	0.00367	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—abdominal aortic aneurysm	0.000555	0.00364	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.000555	0.00363	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000554	0.00363	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000552	0.00362	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000543	0.00356	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.000533	0.00349	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.000532	0.00349	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—CDKN2A—abdominal aortic aneurysm	0.000532	0.00349	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—MMP2—abdominal aortic aneurysm	0.000532	0.00348	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—MMP9—abdominal aortic aneurysm	0.000528	0.00346	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—MMP2—abdominal aortic aneurysm	0.000527	0.00345	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—CDKN2A—abdominal aortic aneurysm	0.000524	0.00344	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.000524	0.00343	CbGpPWpGaD
Minocycline—VEGFA—HIF-2-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000521	0.00342	CbGpPWpGaD
Minocycline—IL1B—Interleukin-1 signaling—NFKB1—abdominal aortic aneurysm	0.000521	0.00341	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.000519	0.0034	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.000515	0.00338	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.000511	0.00335	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—APOE—abdominal aortic aneurysm	0.000508	0.00333	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—abdominal aortic aneurysm	0.000507	0.00332	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.000493	0.00323	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.000491	0.00322	CbGpPWpGaD
Minocycline—MMP9—Osteopontin-mediated events—NFKB1—abdominal aortic aneurysm	0.00049	0.00321	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.000486	0.00318	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.000483	0.00317	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.00048	0.00315	CbGpPWpGaD
Minocycline—MMP9—Collagen formation—MMP3—abdominal aortic aneurysm	0.00048	0.00314	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—NCF1—abdominal aortic aneurysm	0.00048	0.00314	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.000478	0.00313	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—NFKB1—abdominal aortic aneurysm	0.000478	0.00313	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.000469	0.00307	CbGpPWpGaD
Minocycline—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—abdominal aortic aneurysm	0.000464	0.00304	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000461	0.00302	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—NFKB1—abdominal aortic aneurysm	0.00046	0.00302	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.000458	0.003	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—CDKN2A—abdominal aortic aneurysm	0.000455	0.00298	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—NCF1—abdominal aortic aneurysm	0.000453	0.00297	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.000438	0.00287	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—NFKB1—abdominal aortic aneurysm	0.000432	0.00283	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.000429	0.00281	CbGpPWpGaD
Minocycline—ALOX5—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000424	0.00278	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.000419	0.00275	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000418	0.00274	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—MMP2—abdominal aortic aneurysm	0.000412	0.0027	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—AAAS—abdominal aortic aneurysm	0.000409	0.00268	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.000408	0.00268	CbGpPWpGaD
Minocycline—IL1B—IL-1 signaling pathway—NFKB1—abdominal aortic aneurysm	0.000404	0.00265	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—SERPINE1—abdominal aortic aneurysm	0.000404	0.00265	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—MMP9—abdominal aortic aneurysm	0.000399	0.00262	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—NFKB1—abdominal aortic aneurysm	0.000395	0.00259	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—NFKB1—abdominal aortic aneurysm	0.000394	0.00258	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000392	0.00257	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.000392	0.00257	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00039	0.00256	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.00039	0.00255	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.000386	0.00253	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000384	0.00252	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.00038	0.00249	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.000377	0.00247	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—NFKB1—abdominal aortic aneurysm	0.000377	0.00247	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—NFKB1—abdominal aortic aneurysm	0.00037	0.00242	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00037	0.00242	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—MMP2—abdominal aortic aneurysm	0.000369	0.00242	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—CDKN2A—abdominal aortic aneurysm	0.000368	0.00241	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000366	0.0024	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.000364	0.00239	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.000361	0.00237	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.00036	0.00236	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.000357	0.00234	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.000354	0.00232	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.000349	0.00229	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.000344	0.00225	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.000342	0.00224	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000333	0.00218	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000331	0.00217	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.000326	0.00213	CbGpPWpGaD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—NFKB1—abdominal aortic aneurysm	0.000324	0.00212	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—SOD2—abdominal aortic aneurysm	0.000323	0.00212	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000319	0.00209	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—NFKB1—abdominal aortic aneurysm	0.000318	0.00208	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—SERPINE1—abdominal aortic aneurysm	0.000318	0.00208	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—NFKB1—abdominal aortic aneurysm	0.000315	0.00207	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000315	0.00206	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00031	0.00203	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.00031	0.00203	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.00031	0.00203	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000309	0.00202	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—abdominal aortic aneurysm	0.000309	0.00202	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000308	0.00202	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.000307	0.00201	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000307	0.00201	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000302	0.00198	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—NFKB1—abdominal aortic aneurysm	0.000298	0.00195	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—CDKN2A—abdominal aortic aneurysm	0.000297	0.00194	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—NFKB1—abdominal aortic aneurysm	0.000296	0.00194	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000296	0.00194	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.000283	0.00186	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—abdominal aortic aneurysm	0.000283	0.00185	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000279	0.00183	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000279	0.00183	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000277	0.00182	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.000277	0.00181	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—NFKB1—abdominal aortic aneurysm	0.000274	0.0018	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000272	0.00178	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—MMP2—abdominal aortic aneurysm	0.000271	0.00178	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.00027	0.00177	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.000268	0.00175	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000264	0.00173	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.000264	0.00173	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—SERPINE1—abdominal aortic aneurysm	0.000263	0.00172	CbGpPWpGaD
Minocycline—CASP1—Immune System—SELL—abdominal aortic aneurysm	0.000256	0.00167	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000253	0.00166	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—SERPINE1—abdominal aortic aneurysm	0.00025	0.00164	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000246	0.00161	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.000245	0.0016	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—MMP9—abdominal aortic aneurysm	0.000241	0.00158	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.000238	0.00156	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—abdominal aortic aneurysm	0.000236	0.00154	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—NFKB1—abdominal aortic aneurysm	0.000235	0.00154	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000235	0.00154	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000235	0.00154	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000234	0.00153	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.000222	0.00145	CbGpPWpGaD
Minocycline—CASP1—Immune System—AAAS—abdominal aortic aneurysm	0.000214	0.0014	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.000207	0.00135	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SELL—abdominal aortic aneurysm	0.000203	0.00133	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000199	0.0013	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000196	0.00128	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN2A—abdominal aortic aneurysm	0.000194	0.00127	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000194	0.00127	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.000194	0.00127	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—NFKB1—abdominal aortic aneurysm	0.000192	0.00126	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.000192	0.00126	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00019	0.00124	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000183	0.0012	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000183	0.0012	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—abdominal aortic aneurysm	0.000177	0.00116	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.000176	0.00116	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000176	0.00115	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.000175	0.00115	CbGpPWpGaD
Minocycline—CASP1—Immune System—NCF1—abdominal aortic aneurysm	0.000174	0.00114	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000171	0.00112	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000171	0.00112	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000168	0.0011	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000165	0.00108	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000165	0.00108	CbGpPWpGaD
Minocycline—IL1B—Immune System—SELL—abdominal aortic aneurysm	0.00016	0.00105	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—NFKB1—abdominal aortic aneurysm	0.000158	0.00103	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—SOD2—abdominal aortic aneurysm	0.000157	0.00103	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000156	0.00103	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000142	0.00093	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AAAS—abdominal aortic aneurysm	0.000141	0.000926	CbGpPWpGaD
Minocycline—IL1B—Immune System—AAAS—abdominal aortic aneurysm	0.000133	0.000875	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000129	0.000843	CbGpPWpGaD
Minocycline—CYCS—Metabolism—LDLR—abdominal aortic aneurysm	0.000123	0.000808	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00012	0.000786	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000119	0.000782	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000119	0.000782	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000119	0.000778	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.000117	0.000765	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000117	0.000764	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000117	0.000764	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000114	0.00075	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.00011	0.00072	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00011	0.00072	CbGpPWpGaD
Minocycline—IL1B—Immune System—NCF1—abdominal aortic aneurysm	0.000109	0.000714	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000103	0.000673	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—abdominal aortic aneurysm	0.000101	0.000661	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	9.96e-05	0.000653	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	9.93e-05	0.000651	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NFKB1—abdominal aortic aneurysm	9.86e-05	0.000646	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—abdominal aortic aneurysm	9.45e-05	0.000619	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	9.02e-05	0.000591	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	8.84e-05	0.000579	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—abdominal aortic aneurysm	8.75e-05	0.000574	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AAAS—abdominal aortic aneurysm	8.71e-05	0.000571	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LDLR—abdominal aortic aneurysm	8.32e-05	0.000545	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NCF1—abdominal aortic aneurysm	7.78e-05	0.00051	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—NFKB1—abdominal aortic aneurysm	7.67e-05	0.000502	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LRP1—abdominal aortic aneurysm	7.62e-05	0.0005	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LDLR—abdominal aortic aneurysm	7.6e-05	0.000498	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—abdominal aortic aneurysm	7.19e-05	0.000471	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—abdominal aortic aneurysm	7.14e-05	0.000468	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—P2RY12—abdominal aortic aneurysm	7.13e-05	0.000467	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LRP1—abdominal aortic aneurysm	6.62e-05	0.000434	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—abdominal aortic aneurysm	6.58e-05	0.000431	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AGT—abdominal aortic aneurysm	6.52e-05	0.000427	CbGpPWpGaD
Minocycline—CYCS—Metabolism—APOE—abdominal aortic aneurysm	6.39e-05	0.000419	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.25e-05	0.00041	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—abdominal aortic aneurysm	6.24e-05	0.000409	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—P2RY12—abdominal aortic aneurysm	6.19e-05	0.000406	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	6.06e-05	0.000397	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SERPINE1—abdominal aortic aneurysm	6.01e-05	0.000394	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LDLR—abdominal aortic aneurysm	5.78e-05	0.000379	CbGpPWpGaD
Minocycline—CASP1—Immune System—NFKB1—abdominal aortic aneurysm	5.74e-05	0.000376	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.57e-05	0.000365	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCF1—abdominal aortic aneurysm	5.4e-05	0.000354	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NFKB1—abdominal aortic aneurysm	5.35e-05	0.000351	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LDLR—abdominal aortic aneurysm	5.01e-05	0.000329	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—abdominal aortic aneurysm	4.69e-05	0.000308	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCF1—abdominal aortic aneurysm	4.69e-05	0.000307	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NFKB1—abdominal aortic aneurysm	4.64e-05	0.000304	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGT—abdominal aortic aneurysm	4.4e-05	0.000288	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—abdominal aortic aneurysm	4.38e-05	0.000287	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR1—abdominal aortic aneurysm	4.34e-05	0.000284	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—abdominal aortic aneurysm	4.31e-05	0.000282	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGT—abdominal aortic aneurysm	4.02e-05	0.000263	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—abdominal aortic aneurysm	3.94e-05	0.000258	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MMP3—abdominal aortic aneurysm	3.87e-05	0.000253	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	3.77e-05	0.000247	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.62e-05	0.000237	CbGpPWpGaD
Minocycline—IL1B—Immune System—NFKB1—abdominal aortic aneurysm	3.59e-05	0.000235	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.38e-05	0.000222	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP3—abdominal aortic aneurysm	3.36e-05	0.00022	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGT—abdominal aortic aneurysm	3.05e-05	0.0002	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—abdominal aortic aneurysm	2.99e-05	0.000196	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—abdominal aortic aneurysm	2.7e-05	0.000177	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGT—abdominal aortic aneurysm	2.65e-05	0.000174	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—abdominal aortic aneurysm	2.6e-05	0.00017	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.59e-05	0.00017	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.56e-05	0.000168	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.51e-05	0.000165	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.35e-05	0.000154	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.18e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.04e-05	0.000134	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.78e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.56e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.54e-05	0.000101	CbGpPWpGaD
